Adagio Medical ADGM

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.05 (-4.98%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Adagio Medical (ADGM)
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $1.06

  • Market Cap

    $16.30 Million

  • Price-Earnings Ratio

    -0.13

  • Total Outstanding Shares

    15.38 Million Shares

  • Dividend

    No dividend

  • IPO Date

    August 1, 2024

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    26051 merit circle, Laguna hills, CA, 92653

  • Homepage

    https://www.adagiomedical.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities$-22.35 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Gross Profit$-386,000
Research and Development$2.47 Million
Cost Of Revenue$571,000
Net Income/Loss Available To Common Stockholders, Basic$-4.63 Million
Net Income/Loss$-4.63 Million
Net Income/Loss Attributable To Parent$-4.63 Million

Comprehensive Income

July 1, 2024 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-4.64 Million
Other Comprehensive Income/Loss$-8.24 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-4.63 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Other Current Assets$28.56 Million
Current Liabilities$7.92 Million
Inventory$4.14 Million
Prepaid Expenses$2.33 Million
Equity Attributable To Noncontrolling Interest$0
Intangible Assets$26.06 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ADGM from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.